Setback for Alvogen in approval bid for IBS generic

02-11-2023

Marisa Woutersen

Setback for Alvogen in approval bid for IBS generic

Emily frost / Shutterstock.com

District court denies Norwich’s motion to compel FDA to grant approval for its version of popular IBS medication | Court also grants summary judgment in favour of FDA and Norwich’s competitor.


IBS, FDA, ANDA, medication, pharma, patent, US District Court for the District of Columbia, US

LSIPR